712829 http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=712829 RAGNAR: Phase II Study Of Tarlatamab Alone Or In Combination With Chemotherapy In Advanced Neuroendocrine Carcinomas Of The Digestive System Or Unknown Primary Origin 1 on-line https://clinicaltrials.gov/study/NCT07061080 https://euclinicaltrials.eu/search-for-clinical-trials/?lang=en&EUCT=2024-514327-42-00 ES SPAIN European II Tarlatamab 2025-09-01 00:00:00.0 Sponsor of multinational clinical trial GRUPO ESPAÑOL DE TUMORES NEUROENDOCRINOS GRUPO ESPAÑOL DE TUMORES NEUROENDOCRINOS

GRUPO ESPAÑOL DE TUMORES NEUROENDOCRINOS BARCELONA ES SPAIN

Coordinator of multinational clinical trial Tumores Gastrointestinales y Endocrinos

VHIO - Vall d'Hebron Institute of Oncology BARCELONA ES SPAIN

100092 Gastroenteropancreatic neuroendocrine neoplasm Rcl 712830 1 Clinical trial 2 Drug clinical trial FR FRANCE no 2025-08-01 00:00:00.0 2028-12-31 00:00:00.0 712861 1 Clinical trial 2 Drug clinical trial ES SPAIN no 2025-09-10 00:00:00.0 2029-10-15 00:00:00.0